Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer. [electronic resource]
Producer: 20141217Description: 401-6 p. digitalISSN:- 1745-7262
- Androgen Antagonists -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- BRCA2 Protein -- genetics
- Cell Line, Tumor
- Combined Modality Therapy
- Enzyme Inhibitors -- therapeutic use
- Humans
- Hypoxia -- genetics
- Male
- Mutation
- PTEN Phosphohydrolase -- genetics
- Poly (ADP-Ribose) Polymerase-1
- Poly(ADP-ribose) Polymerase Inhibitors
- Prostatic Neoplasms -- drug therapy
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Proto-Oncogene Proteins c-ets -- genetics
- Rad51 Recombinase -- genetics
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.